IFP Advisors’s Actinium Pharmaceuticals ATNM Stock Holding History

IFP Advisors’s Portfolio ATNM Stock Details ATNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-133	Closed	-$1.04K	–	3062
2021 Q1	$1K	Hold	133	–	–	﹤0.01%	2787
2020 Q4	$1K	Hold	133	–	–	﹤0.01%	2723
2020 Q3	$1K	Hold	133	–	–	﹤0.01%	2593
2020 Q2	$1K	Hold	133	–	–	﹤0.01%	2499
2020 Q1	$1K	Hold	133	–	–	﹤0.01%	2486
2019 Q4	$1K	Buy	+133	New	+$918	﹤0.01%	2625

Other funds holding ATNM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

IFP Advisors's ATNM Position: Q2 2021 in Review

IFP Advisors sold out of Actinium Pharmaceuticals (ATNM) in Q2 2021, closing a stake of 133 shares — an estimated $1.04K sold.

IFP Advisors first reported a position in ATNM in Q4 2019 and held it in 6 quarters. The position peaked at $1K in Q1 2021. 37 funds tracked by Wall St. Rank hold ATNM as of Q2 2021.

IFP Advisors reported no remaining Actinium Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
IFP Advisors sold 133 Actinium Pharmaceuticals shares in Q2 2021, an estimated $1.04K.
IFP Advisors first reported a position in Actinium Pharmaceuticals in Q4 2019 and held it in 6 quarters.
IFP Advisors's Actinium Pharmaceuticals position peaked at $1K in Q1 2021.
37 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2021.

Based on IFP Advisors's 13F filing for Q2 2021, filed 13 Jul 2021.